NEUMORA THERAPEUTICS, INC.
NASDAQ: NMRA (Neumora Therapeutics, Inc.)
最近更新时间: 3小时之前3.02
0.02 (0.67%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Neumora Therapeutics, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | -4.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 0.5 |
| 平均 | -0.63 |
|
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 27.57% |
| 机构持股比例 | 60.62% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Softbank Group Corp. | 31 Dec 2025 | 6,429,720 |
| Mic Capital Management Uk Llp | 31 Dec 2025 | 4,460,700 |
| Point72 Asset Management, L.P. | 31 Dec 2025 | 3,673,839 |
| Wellcome Trust Ltd (The) As Trustee Of The Wellcome Trust | 31 Dec 2025 | 3,309,123 |
| Iconiq Capital, Llc | 31 Dec 2025 | 2,559,090 |
| Lunate Capital Ltd | 31 Dec 2025 | 2,124,143 |
| Johnson & Johnson | 31 Dec 2025 | 1,849,445 |
| Renaissance Technologies Llc | 31 Dec 2025 | 1,445,902 |
| Ikarian Capital, Llc | 31 Dec 2025 | 1,278,408 |
| 52周波幅 | ||
| 中 | 8.00 (164.90%) | |
| 总计 | 1 购买 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Leerink Partners | 12 Jan 2026 | 8.00 (164.90%) | 购买 | 2.22 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合